Single-Cell Profiling of the Gut: Uncovering the Roots of Crohn's Disease

Read the full scientific paper here: Single-Cell RNA Sequencing of Terminal Ileal Biopsies Identifies Signatures of Crohn’s Disease Pathogenesis

The Big Picture

Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can be incredibly unpredictable. Symptoms, severity, and how well a person responds to medications vary significantly from patient to patient. To better understand why this happens and to find new ways to treat it, we need to know exactly what is going wrong at the microscopic level of individual cells.

To do this our IBDverse team built the largest to-date, and most detailed, cellular map (atlas) of the terminal ileum—the part of the small intestine most commonly affected by Crohn's disease. This atlas of the terminal ileum offered us the unique opportunity to ask questions about the differences between healthy cells and diseased cells.

How We Did It

We used a cutting-edge technology called single-cell RNA sequencing. Imagine taking a smoothie and being able to pull out and examine every single piece of fruit that went into it. In our case the smoothie is gut tissue and we developed a novel way to gently break down that gut tissue into the thousands and thousands of cells (fruits) that compose each gut biopsy.

Every cell in the body contains the same DNA but cells look, behave and respond differently as a result of how they activate and deactivate different genes in the genome. Some intestinal cells will activate digestive genes to produce enzymes which break down food whilst other intestinal cells will activate immune genes to fight off infection. We know that in the guts of people with IBD, genes are activated and deactivated in a way that can cause disease but before this study it was unclear what was happening at the cellular level.

Our approach allowed us the opportunity to look at the way genes were switched on and off inside over 1.1 million single cells taken from 343 people (111 patients with Crohn's disease and 232 healthy individuals). This allowed us to identify all the different types of cells in the gut and see exactly which ones are misbehaving during a Crohn's flare-up.

What We Found

Our massive dataset revealed several new insights into how Crohn's disease develops and persists in the gut:

1. The Gut Barrier Remembers Inflammation. The cells lining the inside of your gut (epithelial cells) act as a barrier. We found that in Crohn's disease, these cells are stressed by immune signals called "interferons." Surprisingly, these stressed-out signatures were found even in the gut's stem cells (the cells responsible for regenerating the gut lining), and they persisted even after the visible inflammation had healed. This suggests the gut lining holds a "memory" of the inflammation, which might explain why the disease can flare up again in the same spots.
2. Identifying the "Troublemaker" Immune Cells. By mapping out the immune cells, we pinpointed a specific group of cells called ITGA4+ macrophages as key drivers of the disease. In a healthy gut, macrophages help clear away debris. But in Crohn's disease, these specific macrophages produce high levels of inflammatory signals (like IL-6, IL-12, and IL-23) that keep the inflammation going.
3. Connecting the Dots with Genetics We know that genetics play a role in Crohn's disease risk. By combining our single-cell data with genetic data, we were able to link specific genetic risks directly to inflammatory monocytes and macrophages. This proves that both the immune cells that naturally reside in your gut and the ones recruited from your blood during a flare are central to how the disease is triggered in individuals with a genetic predisposition.

What This Means for Patients

While this research is done in a lab, it has real-world implications for the future of Crohn's care:

• Better Targeted Therapies: By identifying the exact cells (like ITGA4+ macrophages) and the exact signals (like IL-23 and interferons) causing the damage, drug developers can design more precise medications that stop inflammation at the source.
• Understanding Relapse: Discovering that healed tissue still carries molecular "scars" or inflammatory memories helps explain why achieving deep, long-lasting remission can be so difficult, and points to new ways we might treat the gut to truly "reset" it.
• A Public Resource: We made the IBDverse dataset open to researchers worldwide. This means scientists everywhere can use our map to speed up their own research, accelerating the path to new treatments and potentially a cure.